Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains. - Wikidata - wikimedia - TriplyDB

Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains.

Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains.

http://www.wikidata.org/entity/Q35273267

about

Live attenuated vaccines for invasive Salmonella infections Vaccines against invasive Salmonella disease: current status and future directions Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections Differing burden and epidemiology of non-Typhi Salmonella bacteremia in rural and urban Kenya, 2006-2009 The Prostaglandin E2-EP3 Receptor Axis Regulates Anaplasma phagocytophilum-Mediated NLRC4 Inflammasome Activation The Tick Protein Sialostatin L2 Binds to Annexin A2 and Inhibits NLRC4-Mediated Inflammasome Activation.Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa.Serum bactericidal assays to evaluate typhoidal and nontyphoidal Salmonella vaccines.The delicate balance in genetically engineering live vaccines.Cell-associated flagella enhance the protection conferred by mucosally-administered attenuated Salmonella Paratyphi A vaccines.Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa.The association between malaria and non-typhoid Salmonella bacteraemia in children in sub-Saharan Africa: a literature review.Metabolic engineering of Salmonella vaccine bacteria to boost human Vγ2Vδ2 T cell immunity.Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates.Invasive Salmonella Typhimurium ST313 with naturally attenuated flagellin elicits reduced inflammation and replicates within macrophages.Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis.Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.Functional Activity of Antibodies Directed towards Flagellin Proteins of Non-Typhoidal Salmonella.Invasive Nontyphoidal Salmonella Infections Among Children in Mali, 2002-2014: Microbiological and Epidemiologic Features Guide Vaccine Development.Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.Attenuated Actinobacillus pleuropneumoniae double-deletion mutant S-8∆clpP/apxIIC confers protection against homologous or heterologous strain challenge.Modeling the Potential for Vaccination to Diminish the Burden of Invasive Non-typhoidal Salmonella Disease in Young Children in Mali, West Africa.Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.Development of novel O-polysaccharide based glycoconjugates for immunization against glanders Protective Immunity Elicited by Oral Immunization of Mice with Salmonella enterica Serovar Typhimurium Braun Lipoprotein (Lpp) and Acetyltransferase (MsbB) Mutants.Immunology, epidemiology and mathematical modelling towards a better understanding of invasive non-typhoidal Salmonella disease and rational vaccination approaches.Vaccination against Salmonella Infection: the Mucosal Way.Outer membrane vesicles derived from Salmonella Typhimurium mutants with truncated LPS induce cross-protective immune responses against infection of Salmonella enterica serovars in the mouse model.Opsonophagocytic Assay To Evaluate Immunogenicity of Nontyphoidal Salmonella Vaccines.Salmonella O48 Serum Resistance is Connected with the Elongation of the Lipopolysaccharide O-Antigen Containing Sialic Acid.A scalable method for biochemical purification of Salmonella flagellin.Invasive nontyphoidal Salmonella disease in Africa: current status.O-Serotype Conversion in Salmonella Typhimurium Induces Protective Immune Responses against Invasive Non-Typhoidal Salmonella Infections.Immunogenicity and efficacy following sequential parenterally-administered doses of Salmonella Enteritidis COPS:FliC glycoconjugates in infant and adult mice.Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa

P2860

Q27003066-A2D75FF0-9603-47DE-8BAD-7E8B7EE3CFC5 Q27007088-D47EEBAD-EA5A-441C-A769-ECD91744E97D Q28084595-83E6173D-7FCD-4AA8-8ABD-B93C01151103 Q28480994-DFF9B0C0-7ABC-4C98-8813-9E4C153F1193 Q28553346-50FDD7A7-AA10-45AA-B6B6-83FB18EEC053 Q33431253-84767C9E-FD6A-4BA9-B364-77ACD68E94C7 Q33579987-531CC9EF-D76E-4A8A-B257-68BAD7C25141 Q33601858-6F65717A-AA46-4EA6-9700-3400215E0BA6 Q33801051-54BBEC9D-8B5E-49AF-85B3-F8DE85E7EE3E Q34070619-9E073950-09ED-412C-838E-3BA696295BD4 Q34275116-C2B6A978-AA6C-4E64-B699-8091C9BDDA93 Q34410190-7558DF6D-70F0-4FF7-BDF7-D790A76B39C8 Q34560345-8A189884-F350-4200-BEC7-2932A30318B9 Q34760675-ED33F604-DAB5-4371-9E39-33189FAD0931 Q34874212-139978C3-E8DE-4703-A391-A2A90A33E42C Q35098175-67EDC7F5-9A19-4700-B72A-17914080D568 Q35272921-6936FFB1-31BE-406B-93C0-0AE0EB26E448 Q35887055-04EE881A-C1E2-4B6E-BEAB-BF64279E6947 Q35964671-D59BC56D-B026-4606-9999-0ED5F3B3AA2D Q36133462-28A85393-3455-44A9-B0D2-AC764D1529A5 Q36164961-1644382E-7D22-45F0-B6C4-A476A9EBF65C Q36184367-E819914E-DBE7-43E1-B18F-403303B666F9 Q36243182-566D058C-AA36-4CD5-B322-BF8B60796C42 Q36275289-E492B170-7B7C-45E5-9F4B-10963BFA4EA4 Q36281257-7A5545CC-6476-494D-9AA8-7A53C723C0C1 Q36424795-FFF33FD4-14BA-4732-BE5C-D90953C92DD4 Q37405767-00322009-A045-4FD6-8293-4AD1A8778BE2 Q38832842-5D53E81F-8BCF-4310-8820-BE0E296CBC52 Q39373957-6B5F4D3A-2950-4B24-AE0A-728E0766076E Q40557181-AB7AC4E7-C195-424B-BB21-91466FE1A0E1 Q40734790-E7870262-FA05-435E-B40F-CE714344D17F Q41995665-E450EB6D-6BD2-42A5-B397-B7B9B3630860 Q42915324-A748BCED-C27E-43C3-B4A3-6F4937CC452D Q45754072-8F1C371F-F4B1-4EBC-A747-F6EC8C0F6D22 Q47103827-7BEC8BEB-CE78-4C24-8904-4C47CF31FCA3 Q54201279-209D9D3E-0B5C-4812-916F-F658C821177C Q58762161-5296E3B6-4C61-4718-B07F-82114034C81F

P2860

Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains.

http://www.wikidata.org/entity/Q35273267

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Engineering and preclinical ev ...... ccines and as reagent strains.

@ast

Engineering and preclinical ev ...... ccines and as reagent strains.

@en

type

label

Engineering and preclinical ev ...... ccines and as reagent strains.

@ast

Engineering and preclinical ev ...... ccines and as reagent strains.

@en

prefLabel

Engineering and preclinical ev ...... ccines and as reagent strains.

@ast

Engineering and preclinical ev ...... ccines and as reagent strains.

@en

P1433

Q35273267-2EB9DF3F-A4F0-4EB9-89DA-61CD239F5D03

P1476

Q35273267-1BE6EE1A-8496-42BF-A437-3BDAB7BC57D7

P2093

Q35273267-28825BFF-6740-4A25-9AD2-6379D42DBAB8

Q35273267-6437C4E7-6202-4859-AA95-40A86190D0F5

Q35273267-712EA5B7-C7F2-4700-B48B-0CCEBF362D48

Q35273267-76B79B7D-410B-44A3-BFC2-4DF1513836C2

Q35273267-9324B2F6-E519-46E3-9A65-4B10B4E27917

Q35273267-C2536F61-88CD-4978-90E4-23EC892211DB

P2860

Q35273267-01348326-A322-414C-8B9F-523AD17C8FF9

Q35273267-03E212F0-ED10-4A8E-95B0-FD1099F22248

Q35273267-06810983-D203-4E44-9F0D-3F6AEB02766B

Q35273267-094B9142-D0BC-4161-9C44-980345AC5BFC

Q35273267-0C59ADC5-E4BA-44E0-A765-04840620C0B4

Q35273267-11A6FA2D-C78B-4A1B-BC25-460672C9E7F3

Q35273267-24CD513E-207B-46D2-934D-4DF128EF5DEC

Q35273267-2591ECF8-BE71-4F7D-9065-61FB70C43E68

Q35273267-27921A11-B74D-4E79-A51B-D7D253BA1B2F

Q35273267-2A5C1562-D067-4C13-84D4-10959DE7ECDD

P304

Q35273267-8F04A302-D993-4D03-954C-528B25132487

P31

Q35273267-60F0CE74-BA88-4F6B-A3BC-D6498720D168

P356

Q35273267-B6BC5738-C8AF-4B51-BBFC-375131053CE1

P407

Q35273267-6ABAEFEE-7EA5-4239-90DD-8D54D3C657C0

P433

Q35273267-BB6123D1-38C2-4C77-89F3-7B6D936099BA

P478

Q35273267-5EA5410B-423F-455F-8149-B4353C976F9C

P50

Q35273267-44C1C397-B51F-4BF1-8626-3A55440F7785

P577

Q35273267-F028E052-FC8E-41A3-B621-247A3AA8DD69

P5875

Q35273267-5DBB59EC-A8CF-4192-B00E-43042AE3544E

P698

Q35273267-1B56A534-5869-47EA-8F83-E26D8A91A1F7

P932

Q35273267-5513D86F-BFF5-495E-8719-5FC4B2B1CC7D

P356

P1433

Infection and Immunity

P1476

Engineering and preclinical ev ...... ccines and as reagent strains.

@en

P2093

James E Galen

http://www.w3.org/2001/XMLSchema#string

Jin-Yuan Wang

http://www.w3.org/2001/XMLSchema#string

Marcela F Pasetti

http://www.w3.org/2001/XMLSchema#string

Orit Gat

http://www.w3.org/2001/XMLSchema#string

Raphael Simon

http://www.w3.org/2001/XMLSchema#string

Sharon M Tennant

http://www.w3.org/2001/XMLSchema#string

P2860

One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products

Characterisation of community acquired non-typhoidal Salmonella from bacteraemia and diarrhoeal infections in children admitted to hospital in Nairobi, Kenya.

Identification by PCR of non-typhoidal Salmonella enterica serovars associated with invasive infections among febrile patients in Mali.

Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans

Unsafe injections in the developing world and transmission of bloodborne pathogens: a review.

Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers.

Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915.

Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers.

Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference.

FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States.

P304

4175-4185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.05278-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P50

Myron M. Levine

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51539116

http://www.w3.org/2001/XMLSchema#string

P698

21807911

http://www.w3.org/2001/XMLSchema#string

P932

3187273

http://www.w3.org/2001/XMLSchema#string